Johnson & Johnson (JNJ) Should Post 1Q19 Upside And Reiterate Guidance - RBC Capital
Tweet Send to a Friend
RBC Capital analyst Brandon Henry reiterated an Outperform rating and $144.00 price target on Johnson & Johnson (NYSE: JNJ) expecting ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
